On the stock market since 2003, it operates in the everyday-essentials business. It has 14,100 employees. Now — the numbers.
This is an established company with proven profits.
That much dependence is a risk in itself: if this one line weakens, the whole company feels it directly.
No real growth (2% a year).
The gap is $3.9B. In times of high interest rates, a gap like that can squeeze a company.
Executives buying with their own money is usually read as confidence in the company’s future.
The stock trades 50% below its peak. The market has trimmed its expectations for the company.
Over the last 12 months, company executives reported 95 buys and 29 sells. Management buying with its own money is usually read as a good sign.
The average analyst price target is $86.33 — 66% above today’s price.
It pays out $1.89 per share each year — regular cash for whoever holds the stock.
Over the last 3 years, sales grew only 3% a year on average. At this size, speeding back up is not easy.
Since the drop from its peak, buyer appetite hasn’t come back.
On our five-subject report card, MKC-V sits behind the class. A low grade doesn’t mean “doomed” — it means “big claim, small proof.”
The takeaway: MKC-V is an established business that has proven its profits for years. The real debate isn’t the quality of the business — it’s whether the price paid for the stock is too high.